Josh Mandel-Brehm

Insider Reports History

Entity
Individual
Location
C/O Promis Neurosciences Inc., Suite 200, 1920 Yonge Street, Toronto, Ontario, Canada
Signature
By: /s/ Thomas Danielski, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Josh Mandel-Brehm:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Camp4 Therapeutics Corp Chief Executive Officer, Director Common Stock 272K Oct 15, 2024 Direct
ProMIS Neurosciences Inc. Director Option (right to buy) 40K Oct 3, 2024 Direct
Camp4 Therapeutics Corp Chief Executive Officer, Director Series B Preferred Stock 0 Oct 15, 2024 Direct

Insider Reports Filed by Josh Mandel-Brehm

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Oct 15, 2024 2 $0 4 Oct 15, 2024 Chief Executive Officer, Director
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 Chief Executive Officer, Director
PMN ProMIS Neurosciences Inc. Oct 3, 2024 1 $0 4 Oct 7, 2024 Director
PMN ProMIS Neurosciences Inc. Jul 7, 2022 0 $0 3 Jul 7, 2022 Director